M
Metri Bio develops first-in-class, targeted therapeutics for debilitating uterine diseases like endometriosis. The company addresses the lack of disease-modifying treatments by focusing on the complex biology of the endometrium. Their platform aims to significantly improve outcomes for women suffering from these widespread conditions.
Updated 2 months ago
Funding
Funding not disclosed
Funding rounds are not available yet.
Founders
Founder details are not available yet.
Product
Features
- Metri Bio develops first-in-class, targeted therapeutics for debilitating endometrial diseases like endometriosis. The company addresses the lack of disease-modifying treatments by leveraging a proprietary platform designed to identify reliable disease targets. This focus aims to significantly improve the quality of life for women suffering from these complex uterine conditions.